Literature DB >> 3062000

General mechanisms of resistance to antibiotics.

L E Bryan1.   

Abstract

Resistance to antimicrobial agents may result from intrinsic properties of organisms, through mutation and through plasmid- and transposon-specified genes. beta-Lactam resistance is most frequently associated with one or more chromosomal- or plasmid-specified beta-lactamases. Recently, mutations modifying penicillin-binding proteins have been detected with increased frequency as a cause of beta-lactam resistance. Mixed mechanisms, reduced permeability and tolerance are other causes of resistance. Aminoglycoside resistance always involves some modification of drug uptake, most often due to a variety of enzymes modifying these compounds. Reduced uptake is a primary cause of resistance in anaerobic bacteria and bacteria growing anaerobically, some strains of Pseudomonas aeruginosa, and mutants that arise during antimicrobial therapy and are defective in energy-generation systems. Resistance to other antimicrobial agents is presented in tabular form.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3062000     DOI: 10.1093/jac/22.supplement_a.1

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  14 in total

1.  Novel plasmid-mediated 16S rRNA methylase, RmtC, found in a proteus mirabilis isolate demonstrating extraordinary high-level resistance against various aminoglycosides.

Authors:  Jun-Ichi Wachino; Kunikazu Yamane; Keigo Shibayama; Hiroshi Kurokawa; Naohiro Shibata; Satowa Suzuki; Yohei Doi; Kouji Kimura; Yasuyoshi Ike; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

2.  Effects of a restrictive antibiotic policy on clinical efficacy of antibiotics and susceptibility patterns of organisms.

Authors:  A W Sturm
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-06       Impact factor: 3.267

Review 3.  Alpha-helical cationic antimicrobial peptides: relationships of structure and function.

Authors:  Yibing Huang; Jinfeng Huang; Yuxin Chen
Journal:  Protein Cell       Date:  2010-02-06       Impact factor: 14.870

4.  Nomenclature of aminoglycoside resistance genes: a comment.

Authors:  J A van de Klundert; J S Vliegenthart
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

5.  Pharmacokinetic and pharmacodynamic approach for comparing two therapeutic regimens using amikacin.

Authors:  M Staneva; B Markova; I Atanasova; D Terziivanov
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

6.  Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.

Authors:  Jun-ichi Wachino; Keigo Shibayama; Hiroshi Kurokawa; Kouji Kimura; Kunikazu Yamane; Satowa Suzuki; Naohiro Shibata; Yasuyoshi Ike; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

7.  Interaction of gentamicin with the A band and B band lipopolysaccharides of Pseudomonas aeruginosa and its possible lethal effect.

Authors:  J L Kadurugamuwa; J S Lam; T J Beveridge
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

8.  Regulation of membrane permeability by a two-component regulatory system in Pseudomonas aeruginosa.

Authors:  Yanping Wang; Unhwan Ha; Lin Zeng; Shouguang Jin
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

9.  Impact of aminoglycoside cycling in six tertiary intensive care units: prospective longitudinal interventional study.

Authors:  Igor Francetić; Smilja Kalenić; Mirjana Huić; Iveta Mercep; Ksenija Makar-Ausperger; Robert Likić; Viktorija Erdeljić; Vesna Tripković; Petra Simić
Journal:  Croat Med J       Date:  2008-04       Impact factor: 1.351

10.  Plasmid-mediated 16S rRNA methylase in Serratia marcescens conferring high-level resistance to aminoglycosides.

Authors:  Yohei Doi; Keiko Yokoyama; Kunikazu Yamane; Jun-Ichi Wachino; Naohiro Shibata; Tetsuya Yagi; Keigo Shibayama; Haru Kato; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.